Mayo Clinic researchers studying the genetics of people who had recently developed dilated cardiomyopathy, one of the most common causes of heart failure, have found a particular gene to target for developing future drug ...
Nov 30, 2023
0
31
A recent study, published in Nature Communications, focuses on the interaction between free fatty acids (FFAs) and GPR84, a G protein-coupled receptor (GPCR).
Nov 22, 2023
0
0
Hormone therapy may be associated with menopause and fertility treatment, but now an SDU-led research team reports that certain intestinal hormones seem to have a beneficial effect on the processes behind the formation of ...
Nov 16, 2023
0
6
Vitamin D plays a large role in overall health, but it can be challenging to absorb sufficient levels—especially in the colder months. A Baylor College of Medicine expert provides tips on how to maintain your vitamin D ...
Nov 10, 2023
0
25
Marta Butrym from the Center for Infectious Medicine (CIM), at the department of Medicine, Huddinge (MedH), is defending her thesis, "Novel vaccines and antiviral treatments for enterovirus induced infections and disease," ...
Nov 6, 2023
0
0
Currently, the United States lacks FDA-approved treatments for liver fibrosis, highlighting the critical need to understand the cellular biology and pathways associated with this condition.
Nov 1, 2023
0
0
Dear Mayo Clinic: My husband and I want to expand our family and are trying to get pregnant with our first baby. I've read about family planning couples can do before conceiving and learned about carrier screening. We don't ...
Oct 19, 2023
0
0
Liver fibrosis is associated with various liver injuries, including viral infection, inflammation, excess alcohol consumption, and metabolic dysfunction. More importantly, the number of patients with metabolic dysfunction-associated ...
Oct 10, 2023
0
18
New research, published in Matrix Biology, has revealed a potential therapeutic target within keloid cells, which could provide new treatments for a range of skin diseases and fibrosis, including keloid scars.
Oct 5, 2023
0
1
A synthetic peptide developed by researchers at the Medical College of Georgia could help reduce vascular problems associated with acute respiratory distress syndrome (ARDS) in COVID-19.
Oct 3, 2023
0
23
